| |
| |
|
| Insider
Information: |
Opko Health, Inc. |
| Relationship: |
10% Owner |
| City: |
Miami |
| State: |
FL |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
5 |
|
| Direct
Shares |
206,814,406 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$2,340,296,316 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
206,814,406 |
|
|
| Total
Value |
$2,340,296,316 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
1
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
1
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
-1.0
|
0.0
|
| Percentage
Gain/Loss : |
 -74.3%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Sorrento Therapeutics Inc |
SRNE |
10% Owner |
2013-11-26 |
2,153,045 |
|
0 |
Premium* |
|
|
Phio Pharmaceuticals Corp |
PHIO |
10% Owner |
2013-03-12 |
67,241,380 |
|
0 |
Premium* |
|
|
Cocrystal Pharma |
COCP |
10% Owner |
2014-03-17 |
18,696,301 |
|
0 |
Premium* |
|
|
Eloxx Pharmaceuticals Inc |
ELOX |
10% Owner |
2017-12-19 |
1,289,818 |
|
0 |
Premium* |
|
|
GeneDx Holdings Corp |
WGS |
10% Owner |
2023-04-11 |
117,433,862 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| WGS |
GeneDx Holdings Corp |
10% Owner |
– – • |
2023-04-11 |
4 |
A |
$0.00 |
$0 |
D/D |
23,148,148 |
117,433,862 |
0 |
- |
|
| WGS |
GeneDx Holdings Corp |
10% Owner |
– – • |
2023-01-26 |
4 |
B |
$0.35 |
$5,000,000 |
D/D |
14,285,714 |
94,285,714 |
2.45 |
% |
|
| WGS |
GeneDx Holdings Corp |
10% Owner |
– – • |
2022-04-29 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
80,000,000 |
|
% |
|
| ELOX |
Eloxx Pharmaceuticals Inc |
10% Owner |
– – • |
2017-12-19 |
4 |
A |
$0.00 |
$0 |
D/D |
495,126 |
1,289,818 |
0 |
- |
|
| ELOX |
Eloxx Pharmaceuticals Inc |
10% Owner |
– – • |
2017-09-19 |
4 |
A |
$0.00 |
$0 |
D/D |
1,250,006 |
15,893,844 |
0 |
- |
|
| ELOX |
Eloxx Pharmaceuticals Inc |
10% Owner |
– – • |
2017-08-10 |
4 |
OE |
$0.10 |
$412,682 |
D/D |
4,126,822 |
14,643,838 |
0 |
- |
|
| ELOX |
Eloxx Pharmaceuticals Inc |
10% Owner |
– – • |
2017-07-28 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
10,517,016 |
|
- |
|
| COCP |
Cocrystal Pharma |
10% Owner |
– – • |
2014-03-17 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
18,696,301 |
|
- |
|
| SRNE |
Sorrento Therapeutics Inc |
10% Owner |
– – • |
2013-11-26 |
4 |
S |
$8.54 |
$74,418 |
D/D |
(8,714) |
2,153,045 |
0 |
- |
|
| SRNE |
Sorrento Therapeutics Inc |
10% Owner |
– – • |
2013-11-25 |
4 |
S |
$8.54 |
$103,345 |
D/D |
(12,100) |
2,161,759 |
0 |
- |
|
| SRNE |
Sorrento Therapeutics Inc |
10% Owner |
– – • |
2013-11-22 |
4 |
S |
$8.50 |
$71,995 |
D/D |
(8,471) |
2,173,859 |
0 |
- |
|
| SRNE |
Sorrento Therapeutics Inc |
10% Owner |
– – • |
2013-11-21 |
4 |
S |
$8.53 |
$36,404 |
D/D |
(4,269) |
2,182,330 |
0 |
- |
|
| SRNE |
Sorrento Therapeutics Inc |
10% Owner |
– – • |
2013-11-20 |
4 |
S |
$8.75 |
$148,418 |
D/D |
(16,962) |
2,186,599 |
0 |
- |
|
| SRNE |
Sorrento Therapeutics Inc |
10% Owner |
– – • |
2013-11-19 |
4 |
S |
$8.75 |
$875 |
D/D |
(100) |
2,203,561 |
0 |
- |
|
| SRNE |
Sorrento Therapeutics Inc |
10% Owner |
– – • |
2013-11-15 |
4 |
S |
$8.75 |
$23,713 |
D/D |
(2,710) |
2,203,661 |
0 |
- |
|
| SRNE |
Sorrento Therapeutics Inc |
10% Owner |
– – • |
2013-11-14 |
4 |
S |
$8.75 |
$16,625 |
D/D |
(1,900) |
2,206,371 |
0 |
- |
|
| SRNE |
Sorrento Therapeutics Inc |
10% Owner |
– – • |
2013-11-13 |
4 |
S |
$8.75 |
$117,749 |
D/D |
(13,457) |
2,208,271 |
0 |
- |
|
| SRNE |
Sorrento Therapeutics Inc |
10% Owner |
– – • |
2013-11-08 |
4 |
S |
$8.75 |
$17,500 |
D/D |
(2,000) |
2,221,728 |
0 |
- |
|
| SRNE |
Sorrento Therapeutics Inc |
10% Owner |
– – • |
2013-11-07 |
4 |
S |
$9.07 |
$49,153 |
D/D |
(5,418) |
2,223,728 |
0 |
- |
|
| SRNE |
Sorrento Therapeutics Inc |
10% Owner |
– – • |
2013-11-06 |
4 |
S |
$9.03 |
$1,038,107 |
D/D |
(114,962) |
2,229,146 |
0 |
- |
|
| COCP |
Cocrystal Pharma |
|
– – – |
2013-10-08 |
144 |
NP |
$0.00 |
$350,500 |
/ |
701,000 |
0 |
|
- |
|
| SRNE |
Sorrento Therapeutics Inc |
10% Owner |
– – • |
2013-09-04 |
4 |
S |
$7.75 |
$72,516 |
D/D |
(9,355) |
2,344,108 |
0 |
- |
|
| SRNE |
Sorrento Therapeutics Inc |
10% Owner |
– – • |
2013-08-29 |
4 |
S |
$7.75 |
$775 |
D/D |
(100) |
2,353,463 |
0 |
- |
|
| SRNE |
Sorrento Therapeutics Inc |
10% Owner |
– – • |
2013-08-28 |
4 |
S |
$7.75 |
$4,968 |
D/D |
(641) |
2,353,563 |
0 |
- |
|
| SRNE |
Sorrento Therapeutics Inc |
10% Owner |
– – • |
2013-08-26 |
4 |
S |
$8.00 |
$12,920 |
D/D |
(1,615) |
2,354,204 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
